Saptalis Pharmaceuticals LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 20 Davids Drive, Hauppauge, New York (NY) 11788, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 3012152381 · DUNS 081154447
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-03-06
- NAIBioresearch Monitoring2025-09-09
- VAIDrug Quality Assurance2023-03-17
- VAIDrug Quality Assurance2018-03-28
Drugs this plant is listed as making
15 distinct drugs across 21 products name this site in their FDA label.
- Acetic AcidTruPharma, LLC
- Clotrimazole Topical Solution USP, 1%ScieGen Pharmaceuticals, Inc
- DesoximetasoneSaptalis Pharmaceuticals, LLC.
- FluocinonideSaptalis Pharmaceuticals, LLC.
- FluoxetineSaptalis Pharmaceuticals, LLC.
- Hydrocortisone Acetate, Pramoxine HClTrupharma, Llc
- LevocarnitineTrupharma, Llc
- Levocarnitine OralSaptalis Pharmaceuticals, LLC
- Metformin HydrochlorideTrupharma, Llc
- Metronidazole OralKesin Pharma Corporation
- NitroglycerinSolaris Pharma Corporation
- Potassium ChlorideKesin Pharma Corporation
- Potassium Chloride OralSaptalis Pharmaceuticals, LLC
- triamcinolone acetonideMicro Labs Limited
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.